More broadly, there are questions to be asked about where the single market stops, and how far new laws need to be passed in order to make the single market function efficiently.
As a patchwork solution, some drugmakers first seek approval of a new single-ingredient drug that contains a new active moiety in order to secure five years of exclusivity.